Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Haining Zhuluoji Biotechnology Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner in 1 distinct art unit. CHANG, KYUNG SOOK is the examiner assigned to this case.
CHANG, KYUNG SOOK is the busiest examiner for the portfolio, currently managing 1 pending office action. This represents the entirety of the company's active prosecution in the Biotechnology & Pharmaceuticals field. The 1 distinct art unit indicates a concentrated technical focus for this specific patent application.
The prosecution is centralized under 1 distinct examiner. Practitioners can focus their efforts on the specific preferences and history of CHANG, KYUNG SOOK. With only 1 pending office action, the company's immediate patent success in the Biotechnology & Pharmaceuticals sector is tied to this single matter in 1 distinct art unit. This requires a precise and well-supported response to the pending action to advance the application toward allowance.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANG, KYUNG SOOK | 1 | 60.4% | +40.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275214 | MEDICAL TISSUE ADHESIVE AND PREPARATION METHOD THEREOF | CHANG, KYUNG SOOK | 7d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275214 | MEDICAL TISSUE ADHESIVE AND PREPARATION METHOD THEREOF | CHANG, KYUNG SOOK | 7d |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18275214 | MEDICAL TISSUE ADHESIVE AND PREPARATION METHOD THEREOF | CHANG, KYUNG SOOK | 1613 | §103§112 | Final Rejection | 7d | Pending | Aug 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial